Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Stranica 1 iz 24 rezultatima
Indole amide compound as inhibitor of necrosis
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
TECHNICAL FIELD
The present invention relates to an indole amide compound of Formula (1), a pharmaceutically acceptable salt or isomer thereof, and a composition and a method of preparing a composition for the prevention or treatment of cellular necrosis and necrosis-associated diseases comprising
Interleukin-1 and tumor necrosis factors-.alpha. modulators, syntheses of said modulators and methods of using modulators
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION
The invention relates to chemical compounds and pharmaceutical compositions, including novel chemical compounds and pharmaceutical compositions thereof, useful in the treatment of various diseases and disease states. The invention also relates to methods of synthesizing
Cyclic amides
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
The present invention relates a method of reducing levels of TNF.alpha. in a mammal and to compounds and compositions useful therein.
TNF.alpha., or tumor necrosis factor .alpha., is a cytokine which is released primarily by mononuclear phagocytes in response to various
Cyclic amides
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
The present invention relates a method of reducing levels of TNF.alpha. in a mammal and to compounds and compositions useful therein.
TNF, or tumor necrosis factor .alpha., is a cytokine which is released primarily by mononuclear phagocytes in response to various
Cyclic amides
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
The present invention relates a method of reducing levels of TNF.alpha. in a mammal and to compounds and compositions useful therein. TNF.alpha., or tumor necrosis factor .alpha., is a cytokine which is released primarily by mononuclear phagocytes in response to various
Cyclic amides
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
The present invention relates a method of reducing levels of TNF.alpha. in a mammal and to compounds and compositions useful therein.
TNF.alpha., or tumor necrosis factor .alpha., is a cytokine which is released primarily by mononuclear phagocytes in response to various
Immunotherapeutic aryl amides
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
The present invention relates a method of reducing levels of TNF.alpha. in a mammal and to compounds and compositions useful therein.
TNF.alpha., or tumor necrosis factor .alpha., is a cytokine which is released primarily by mononuclear phagocytes in response to various
Immunotherapeutic aryl amides
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
The present invention relates a method of reducing levels of TNF.alpha. in a mammal and to compounds and compositions useful therein.
TNF.alpha., or tumor necrosis factor .alpha., is a cytokine which is released primarily by mononuclear phagocytes in response to various
Immunotherapeutic aryl amides
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
The present invention relates a method of reducing levels of TNF.alpha. in a mammal and to compounds and compositions useful therein.
TNF.alpha., or tumor necrosis factor .alpha., is a cytokine which is released primarily by mononuclear phagocytes in response to various
Immunotherapeutic imides/amides
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
The present invention relates to a method of reducing levels of TNF.alpha. and inhibiting phosphodiesterase in a mammal and to compounds and compositions useful therein.
TNF.alpha., or rumor necrosis factor .alpha., is a cytokine which is released primarily by mononuclear
Necrosis inhibitors
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
INTRODUCTION
Tumor necrosis factor alpha (TNF-.alpha.)-induced NF-.kappa.B activation plays a central role in the immune system and inflammatory responses. Receptor-interacting protein 1 (RIP1) is a multi-functional signal transducer involved in mediating nuclear factor-.kappa.B (NF-.kappa.B)
Necrosis inhibitors
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
INTRODUCTION
Tumor necrosis factor alpha (TNF-.alpha.)-induced NF-.kappa.B activation plays a central role in the immune system and inflammatory responses. Receptor-interacting protein 1 (RIP1) is a multi-functional signal transducer involved in mediating nuclear factor .kappa.B (NF-.kappa.B)
Necrosis inhibitors
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
INTRODUCTION
Tumor necrosis factor alpha (TNF-.alpha.)-induced NF-.kappa.B activation plays a central role in the immune system and inflammatory responses. Receptor-interacting protein 1 (RIP1) is a multi-functional signal transducer involved in mediating nuclear factor .kappa.B (NF-.kappa.B)
Necrosis inhibitors
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Tumor necrosis factor alpha (TNF-.alpha.)-induced NF-.kappa.B activation plays a central role in the immune system and inflammatory responses. Receptor-interacting protein 1 (RIP1) is a multi-functional signal transducer involved in mediating nuclear factor .kappa.B (NF-.kappa.B) activation,
Interleukin-1 and tumor necrosis factor-.alpha. modulators, synthesis of said modulators and their enantiomers and methods of using said modulators
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION
The invention relates to chemical compounds and pharmaceutical compositions, including novel chemical compounds and pharmaceutical compositions thereof, useful in the treatment of various diseases and disease states. The invention also relates to methods of synthesizing
Najkompletnija baza ljekovitog bilja potpomognuta znanošću
- Radi na 55 jezika
- Biljni lijekovi potpomognuti znanošću
- Prepoznavanje bilja slikom
- Interaktivna GPS karta - označite bilje na mjestu (uskoro)
- Pročitajte znanstvene publikacije povezane s vašom pretragom
- Pretražite ljekovito bilje po učincima
- Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima
Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima
